TABLE 6.

Matrix of pairwise comparisons on HB drop (g/dL) in intravenous (mg/kg) administration (shown as mean difference and 95% confidence intervals)

	150 mg/kg EACA IV	20 mg/kg TXA IV	30 mg/kg TXA IV	Placebo
150 mg/kg EACA IV	1	0.18 (−0.74, 1.05)	−0.33 (−1.37, 0.88)	1.02 (0.16, 1.93)
20 mg/kg TXA IV	−0.18 (−1.05, 0.74)	1	−0.51 (−1.29, 0.5)	0.84 (0.33, 1.46)
30 mg/kg TXA IV	0.33 (−0.88, 1.37)	0.51 (−0.5, 1.29)	1	1.36 (0.6, 1.98)
Placebo	−1.02 (−1.93, −0.16)	−0.84 (−1.46, −0.33)	−1.36 (−1.98, −0.6)	1

Note: Bold results mean statistically significance.

Abbreviations: IA, intra‐articular; TXA, tranexamic acid; EACA, aminocaproic acid.